S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas.
Journal Information
Full Title: Neoplasia
Abbreviation: Neoplasia
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."
Funding Disclosure
Evidence found in paper:
"Acknowledgements and Funding The study was supported by the Canadian Institutes of Health Research (CIHR) grants, PJT-156225 and PJT-148821, awarded to Shafaat A. Rabbani and Ciriaco A. Piccirillo, respectively. Ali Mehdi is recipient of Fonds de recherche du Québec – Santé (FRQ-S) scholarship."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025